Silexion Therapeutics Corp SLXN

$1.31 -0.19 (-12.67%)

Valuation

Market cap
851,000
Revenue TTM
$0
Net income TTM
$-11,910,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
16,400
Avg volume
448,958
Day's range
$1.28 – $1.40
Shares out
650,000
Stochastic %K
2%
Beta
-0.30
Analysts
Moderate Buy
Price target
$119.90

Price

Company profile

Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 3 756 4999
Website
https://silexion.com
Address
12 Abba Hillel Road, Ramat Gan, Israel

Latest news

Stocktwits

GridironGainz Nov 19, 10:12 PM 0 replies
GridironGainz Nov 19, 9:00 PM 0 replies
doctorslopadopolis Nov 19, 1:49 PM 0 replies
only1mc Nov 19, 1:49 PM
$SEAT $SLXN get up there
0 replies
only1mc Nov 19, 1:23 PM
$SEAT back in 2.04 $SLXN . at in here at these levels. nesting the egg.
0 replies
ZacksResearch Nov 18, 1:35 PM
"$SLXN has crashed 83.3% in three months — bargain opportunity or value trap? ⚠️ 📉 Trailing P/B of just 0.13 vs. the industry average of 3.51 📊 Trading below its 5-year median P/B of 0.51 ⚖️ 2026 loss estimates have remained stable over the past 30 days Is SLXN a buy, sell, or hold at these levels? See what Wall Street analysts recommend 👉 " https://www.zacks.com/stock/research/SLXN/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-40144&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_40144
0 replies
Johnnyshots Nov 17, 4:06 PM
$SLXN took a position before news and the crowd
0 replies
only1mc Nov 17, 3:40 PM
$FRTT $OMH me taking purifies throwing them in omaha.. another reminder $SLXN will run like $OMH. . start building your nest egg if you choose. just dosed phase 2/3 1 for 24 RS. 600k float. news drops id day before feb. and the breaks will be off . 20+ easy on pancreatic cancer positives . tellin ya
0 replies